Actinogen Medical (Australia) Today
| ACW Stock | 0.03 0 8.33% |
Performance0 of 100
| Odds Of DistressOver 68
|
Actinogen Medical is selling for under 0.026 as of the 22nd of November 2024; that is 8.33 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.024. Actinogen Medical has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Actinogen Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of October 2007 | Category Healthcare | Classification Health Care |
Actinogen Medical is entity of Australia. It is traded as Stock on AU exchange. The company has 3.08 B outstanding shares. More on Actinogen Medical
Moving together with Actinogen Stock
Moving against Actinogen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Actinogen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Actinogen Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Actinogen Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO MD | MBBS FRACP | ||||
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Actinogen Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Actinogen Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsActinogen Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Actinogen Medical's financial leverage. It provides some insight into what part of Actinogen Medical's total assets is financed by creditors.
| |||||
Actinogen Medical (ACW) is traded on Australian Securities Exchange in Australia and employs 11 people. Actinogen Medical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 80.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Actinogen Medical's market, we take the total number of its shares issued and multiply it by Actinogen Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Actinogen Medical operates under Biotechnology sector and is part of Health Care industry. The entity has 3.08 B outstanding shares.
Actinogen Medical has accumulated about 7.18 M in cash with (16.95 M) of positive cash flow from operations.
Check Actinogen Medical Probability Of Bankruptcy
Ownership AllocationActinogen Medical holds a total of 3.08 Billion outstanding shares. Actinogen Medical shows 15.6 percent of its outstanding shares held by insiders and 8.02 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Actinogen Ownership Details
Actinogen Medical Risk Profiles
Although Actinogen Medical's alpha and beta are two of the key measurements used to evaluate Actinogen Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.11 | |||
| Semi Deviation | 4.28 | |||
| Standard Deviation | 11.87 | |||
| Variance | 140.83 |
Actinogen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Actinogen Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Actinogen Medical Corporate Management
Elected by the shareholders, the Actinogen Medical's board of directors comprises two types of representatives: Actinogen Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Actinogen. The board's role is to monitor Actinogen Medical's management team and ensure that shareholders' interests are well served. Actinogen Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Actinogen Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| DCPSA FFPM | Chief Officer | Profile | |
| BCom IPAA | Chief Officer | Profile | |
| MAppFin BFinAdmin | Chief Officer | Profile | |
| BBus FCIS | Company Sec | Profile | |
| Michael Roberts | Head Communications | Profile | |
| Christian Toouli | Head Devel | Profile |
Additional Tools for Actinogen Stock Analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.